Table of Contents
EXECUTIVE SUMMARY
A detailed and comprehensive overview of current financial position, company
strategy, product and pipeline analysis.
THERAPEUTIC AREA FOCUS
- Key product analysis and forecasting
- Cardiovascular
- Zanidip/Zanedip (lercanidipine)
- Central Nervous System
- Elopram (citalopram)
- Entact (escitalopram)
- Tradorec XL (tramadol)
- Gastroenterology/Urology
- Peptazol/Ulcotenal (pantoprazole)
- Respiratory
- Exomuc and Hexa (acetylcysteine and biclotimol)
- Anti-Infectives
- Isocef (ceftibuten)
OPERATIONAL DATA
- A wealth of background and detail
- A full 5-year financial performance assessment
- Key agreements
- Infrastructure
- Subsidiaries and joint ventures
| 
View Cart
